keyword
https://read.qxmd.com/read/38640861/lycium-barbarum-glycopeptide-ameliorates-motor-and-visual-deficits-in-autoimmune-inflammatory-diseases
#21
JOURNAL ARTICLE
Li Xu, Lu Yang, Huiming Xu, Yuhan Li, Fuhua Peng, Wei Qiu, Changyong Tang
BACKGROUND: Lycium barbarum glycopeptide (LbGp), extracted from the traditional Chinese medicine (TCM) of Lycium barbarum (LB), provides a neuroprotective effect against neurodegenerative and neuroimmune disorders contributing to its immunomodulatory and anti-inflammatory roles. Neuromyelitis optica spectrum disorders (NMOSD) is an autoimmune-mediated central nervous system (CNS) demyelinating disease, clinically manifested as transverse myelitis (TM) and optic neuritis. However, no drug has been demonstrated to be effective in relieving limb weakness and visual impairment of NMOSD patients...
April 16, 2024: Phytomedicine
https://read.qxmd.com/read/38640454/does-the-side-of-onset-influence-symptom-severity-in-parkinson-s-disease-a-systematic-review-and-meta-analysis
#22
REVIEW
Nancy Marano, Annukka K Lindell
Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by motor symptoms that initially manifest unilaterally. Whilst some studies indicate that right-side onset is associated with greater symptom severity, others report no differences between right-side and left-side onset patients. The present meta-analysis was thus designed to reconcile inconsistencies in the literature and determine whether side of onset affects PD symptom severity. Following the PRISMA guidelines 1013 studies were initially identified in database and grey literature searches; following title and abstract, and full text, screening 34 studies met the stringent inclusion criteria ( n  = 2210)...
April 19, 2024: Applied Neuropsychology. Adult
https://read.qxmd.com/read/38637880/exploring-the-role-of-prx-ii-in-mitigating-endoplasmic-reticulum-stress-and-mitochondrial-dysfunction-in-neurodegeneration
#23
JOURNAL ARTICLE
Mei-Hua Jin, Lin Feng, Hong-Yi Xiang, Hu-Nan Sun, Ying-Hao Han, Taeho Kwon
BACKGROUND: Neurodegenerative diseases are increasingly recognized for their association with oxidative stress, which leads to progressive dysfunction and loss of neurons, manifesting in cognitive and motor impairments. This study aimed to elucidate the neuroprotective role of peroxiredoxin II (Prx II) in counteracting oxidative stress-induced mitochondrial damage, a key pathological feature of neurodegeneration. METHODS: We investigated the impact of Prx II deficiency on endoplasmic reticulum stress and mitochondrial dysfunction using HT22 cell models with knocked down and overexpressed Prx II...
April 18, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38636794/lrp1-in-gabaergic-neurons-is-a-key-link-between-obesity-and-memory-function
#24
JOURNAL ARTICLE
Kellen Cristina da Cruz Rodrigues, Seung Chan Kim, Aaron Aykut Uner, Zhi-Shuai Hou, Jennie Young, Clara Campolim, Ahmet Aydogan, Brendon Chung, Anthony Choi, Won-Mo Yang, Woojin S Kim, Vincent Prevot, Barbara J Caldarone, Hyon Lee, Young-Bum Kim
OBJECTIVE: Low-density lipoprotein receptor-related protein-1 (LRP1) regulates energy homeostasis, blood-brain barrier integrity, and metabolic signaling in the brain. Deficiency of LRP1 in inhibitory gamma-aminobutyric acid (GABA)ergic neurons causes severe obesity in mice. However, the impact of LRP1 in inhibitory neurons on memory function and cognition in the context of obesity is poorly understood. METHODS: Mice lacking LRP1 in GABAergic neurons (Vgat-Cre; LRP1loxP/loxP ) underwent behavioral tests for locomotor activity and motor coordination, short/long-term and spatial memory, and fear learning/memory...
April 16, 2024: Molecular Metabolism
https://read.qxmd.com/read/38636436/improved-synthesis-and-application-of-an-alkyne-functionalized-isoprenoid-analogue-to-study-the-prenylomes-of-motor-neurons-astrocytes-and-their-stem-cell-progenitors
#25
JOURNAL ARTICLE
Kiall F Suazo, Vartika Mishra, Sanjay Maity, Shelby A Auger, Katarzyna Justyna, Alexandru M Petre, Linda Ottoboni, Jessica Ongaro, Stefania P Corti, Francesco Lotti, Serge Przedborski, Mark D Distefano
Protein prenylation is one example of a broad class of post-translational modifications where proteins are covalently linked to various hydrophobic moieties. To globally identify and monitor levels of all prenylated proteins in a cell simultaneously, our laboratory and others have developed chemical proteomic approaches that rely on the metabolic incorporation of isoprenoid analogues bearing bio-orthogonal functionality followed by enrichment and subsequent quantitative proteomic analysis. Here, several improvements in the synthesis of the alkyne-containing isoprenoid analogue C15AlkOPP are reported to improve synthetic efficiency...
April 16, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38633814/deep-learning-modeling-of-rare-noncoding-genetic-variants-in-human-motor-neurons-defines-ccdc146-as-a-therapeutic-target-for-als
#26
Sai Zhang, Tobias Moll, Jasper Rubin-Sigler, Sharon Tu, Shuya Li, Enming Yuan, Menghui Liu, Afreen Butt, Calum Harvey, Sarah Gornall, Elham Alhalthli, Allan Shaw, Cleide Dos Santos Souza, Laura Ferraiuolo, Eran Hornstein, Tatyana Shelkovnikova, Charlotte H van Dijk, Ilia S Timpanaro, Kevin P Kenna, Jianyang Zeng, Philip S Tsao, Pamela J Shaw, Justin K Ichida, Johnathan Cooper-Knock, Michael P Snyder
Amyotrophic lateral sclerosis (ALS) is a fatal and incurable neurodegenerative disease caused by the selective and progressive death of motor neurons (MNs). Understanding the genetic and molecular factors influencing ALS survival is crucial for disease management and therapeutics. In this study, we introduce a deep learning-powered genetic analysis framework to link rare noncoding genetic variants to ALS survival. Using data from human induced pluripotent stem cell (iPSC)-derived MNs, this method prioritizes functional noncoding variants using deep learning, links cis-regulatory elements (CREs) to target genes using epigenomics data, and integrates these data through gene-level burden tests to identify survival-modifying variants, CREs, and genes...
April 1, 2024: medRxiv
https://read.qxmd.com/read/38632654/igm-anti-gm2-antibodies-in-patients-with-multifocal-motor-neuropathy-target-schwann-cells-and-are-associated-with-early-onset
#27
JOURNAL ARTICLE
Kevin Budding, Jeroen W Bos, Kim Dijkxhoorn, Elisabeth de Zeeuw, Lauri M Bloemenkamp, Eva M Zekveld, Ewout J N Groen, Bart C Jacobs, Ruth Huizinga, H Stephan Goedee, Elisabeth A Cats, Jeanette H W Leusen, Leonard H van den Berg, C Erik Hack, W Ludo van der Pol
BACKGROUND: Multifocal motor neuropathy (MMN) is a rare, chronic immune-mediated polyneuropathy characterized by asymmetric distal limb weakness. An important feature of MMN is the presence of IgM antibodies against gangliosides, in particular GM1 and less often GM2. Antibodies against GM1 bind to motor neurons (MNs) and cause damage through complement activation. The involvement of Schwann cells (SCs), expressing GM1 and GM2, in the pathogenesis of MMN is unknown. METHODS: Combining the data of our 2007 and 2015 combined cross-sectional and follow-up studies in Dutch patients with MMN, we evaluated the presence of IgM antibodies against GM1 and GM2 in serum from 124 patients with MMN and investigated their binding to SCs and complement-activating properties...
April 17, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38630432/structural-functional-and-genetic-changes-surrounding-electrodes-implanted-in-the-brain
#28
JOURNAL ARTICLE
Bhavna Gupta, Akash Saxena, Mason L Perillo, Lauren C Wade-Kleyn, Cort H Thompson, Erin K Purcell
ConspectusImplantable neurotechnology enables monitoring and stimulating of the brain signals responsible for performing cognitive, motor, and sensory tasks. Electrode arrays implanted in the brain are increasingly used in the clinic to treat a variety of sources of neurological diseases and injuries. However, the implantation of a foreign body typically initiates a tissue response characterized by physical disruption of vasculature and the neuropil as well as the initiation of inflammation and the induction of reactive glial states...
April 17, 2024: Accounts of Chemical Research
https://read.qxmd.com/read/38630337/neuroprotective-effect-of-sterculia-setigera-leaves-hydroethanolic-extract
#29
JOURNAL ARTICLE
Yendubé T Kantati, Magloire K Kodjo, Benjamin Lefranc, Magali Basille-Dugay, Sébastien Hupin, Isabelle Schmitz, Jérôme Leprince, Messanvi Gbeassor, David Vaudry
Plants are a valuable source of information for pharmacological research and new drug discovery. The present study aimed to evaluate the neuroprotective potential of the leaves of the medicinal plant Sterculia setigera. In vitro, the effect of Sterculia setigera leaves dry hydroethanolic extract (SSE) was tested on cultured cerebellar granule neurons (CGN) survival when exposed to hydrogen peroxide (H2 O2 ) or 6-hydroxydopamine (6-OHDA), using the viability probe fluorescein diacetate (FDA), a lactate dehydrogenase (LDH) activity assay, an immunocytochemical staining against Gap 43, and the quantification of the expression of genes involved in apoptosis, necrosis, or oxidative stress...
April 17, 2024: Journal of Molecular Neuroscience: MN
https://read.qxmd.com/read/38628040/experiences-of-predictive-genetic-testing-in-inherited-motor-neuron-disease-findings-from-a-qualitative-interview-study
#30
JOURNAL ARTICLE
Jade Howard, Karen Forrest Keenan, Fadhila Mazanderani, Martin R Turner, Louise Locock
Predictive genetic testing is increasingly available for individuals with a heightened risk of motor neuron disease (MND). However, little is known about how they decide whether or not to get tested, and how they experience this process. This paper reports findings from a constructivist grounded theory-informed interview study with 24 family members of people with identified or suspected inherited MND (iMND). Fourteen did not know their genetic status, and nine had decided to have predictive testing, of whom six tested positive for the pathogenic gene variant identified in their family and three tested negative...
April 16, 2024: Journal of Genetic Counseling
https://read.qxmd.com/read/38627751/longitudinal-alterations-in-brain-perfusion-and-vascular-reactivity-in-the-zq175dn-mouse-model-of-huntington-s-disease
#31
JOURNAL ARTICLE
Tamara Vasilkovska, Somaie Salajeghe, Verdi Vanreusel, Johan Van Audekerke, Marlies Verschuuren, Lydiane Hirschler, Jan Warnking, Isabel Pintelon, Dorian Pustina, Roger Cachope, Ladislav Mrzljak, Ignacio Muñoz-Sanjuan, Emmanuel L Barbier, Winnok H De Vos, Annemie Van der Linden, Marleen Verhoye
BACKGROUND: Huntington's disease (HD) is marked by a CAG-repeat expansion in the huntingtin gene that causes neuronal dysfunction and loss, affecting mainly the striatum and the cortex. Alterations in the neurovascular coupling system have been shown to lead to dysregulated energy supply to brain regions in several neurological diseases, including HD, which could potentially trigger the process of neurodegeneration. In particular, it has been observed in cross-sectional human HD studies that vascular alterations are associated to impaired cerebral blood flow (CBF)...
April 16, 2024: Journal of Biomedical Science
https://read.qxmd.com/read/38627469/long-term-benefits-of-hematopoietic-stem-cell-based-macrophage-microglia-delivery-of-gdnf-to-the-cns-in-a-mouse-model-of-parkinson-s-disease
#32
JOURNAL ARTICLE
Guo Ge, Barath P Sivasubramanian, Bill D Geng, Shujie Zhao, Qing Zhou, Gang Huang, Jason C O'Connor, Robert A Clark, Senlin Li
Glial cell line-derived neurotrophic factor (GDNF) protects dopaminergic neurons in various models of Parkinson's disease (PD). Cell-based GDNF gene delivery mitigates neurodegeneration and improves both motor and non-motor functions in PD mice. As PD is a chronic condition, this study aims to investigate the long-lasting benefits of hematopoietic stem cell (HSC)-based macrophage/microglia-mediated CNS GDNF (MMC-GDNF) delivery in an MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model. The results indicate that GDNF treatment effectively ameliorated MPTP-induced motor deficits for up to 12 months, which coincided with the protection of nigral dopaminergic neurons and their striatal terminals...
April 16, 2024: Gene Therapy
https://read.qxmd.com/read/38625964/neuroprotective-potential-of-mentha-piperita-extract-prevents-motor-dysfunctions-in-mouse-model-of-parkinson-s-disease-through-anti-oxidant-capacities
#33
JOURNAL ARTICLE
Rabia Anjum, Chand Raza, Mehwish Faheem, Arif Ullah, Maham Chaudhry
Parkinson's disease (PD) is the second most common neurodegenerative disease in the world. Neurodegeneration of the substantia nigra (SN) and diminished release of dopamine are prominent causes of this progressive disease. The current study aims to evaluate the protective potential of ethanolic extract of Mentha piperita (EthMP) against rotenone-mediated PD features, dopaminergic neuronal degeneration, oxidative stress and neuronal survival in a mouse model. Swiss albino male mice were assigned to five groups: control (2...
2024: PloS One
https://read.qxmd.com/read/38625841/enhanced-levels-of-fractalkine-and-hsp60-in-cerebrospinal-fluid-of-sporadic-amyotrophic-lateral-sclerosis-patients
#34
JOURNAL ARTICLE
Rashmi Savant, Raj Kumar Pradhan, Savita Bhagat, Rajeswara Babu Mythri, Anu Mary Varghese, Seena Vengalil, Atchayaram Nalini, Talakad N Sathyaprabha, Trichur R Raju, K Vijayalakshmi
Amyotrophic Lateral Sclerosis (ALS) is a multifactorial neurodegenerative disorder with a significant contribution of non-cell autonomous mechanisms to motor neuronal degeneration. Amongst a plethora of molecules, Fractalkine (C-X3-C motif chemokine ligand 1), and Heat Shock Protein 60 (HSP60), are key modulators of microglial activation. The contribution of these molecules in Sporadic ALS (SALS) remains unexplored. To investigate this, fractalkine levels were estimated in Cerebrospinal fluid (CSF) of SALS patients (ALS-CSF; n = 44) by Enzyme-linked Immunosorbent Assay (ELISA) and correlated with clinical parameters including disease severity and duration...
April 16, 2024: International Journal of Neuroscience
https://read.qxmd.com/read/38625397/molecular-dynamic-investigation-for-roco4-kinase-inhibitor-as-treatment-options-for-parkinsonism
#35
JOURNAL ARTICLE
Kankana Dutta, Lokesh Ravi
CONTEXT: Parkinson's disease is a neurodegenerative condition characterized by the degeneration of dopaminergic neurons, resulting in motor disabilities such as rigidity, bradykinesia, postural instability, and resting tremors. While the exact cause of Parkinson's remains uncertain, both familial and sporadic forms are often associated with the G2019S mutation found in the kinase domain of LRRK2. Roco4 is an analogue of LRRK2 protein in Dictyostelium discoideum which is an established model organism to investigate LRRK2 inhibitors...
April 16, 2024: Journal of Molecular Modeling
https://read.qxmd.com/read/38622810/teaghrelin-protected-dopaminergic-neurons-in-mptp-induced-parkinson-s-disease-animal-model-by-promoting-pink1-parkin-mediated-mitophagy-and-ampk-sirt1-pgc1-%C3%AE-mediated-mitochondrial-biogenesis
#36
JOURNAL ARTICLE
Cian-Fen Jhuo, Chun-Jung Chen, Jason T C Tzen, Wen-Ying Chen
Mitochondrial dysfunction, a common cellular hallmark in both familial and sporadic forms of Parkinson's disease (PD), is assumed to play a significant role in pathologic development and progression of the disease. Teaghrelin, a unique bioactive compound in some oolong tea varieties, has been demonstrated to protect SH-SY5Y cells against 1-methyl-4-phenylpyridinium induced neurotoxicity by binding to the ghrelin receptor to activate the AMPK/SIRT1/PGC-1α pathway. In this study, an animal model was established using a neurotoxin, 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP), a byproduct of a prohibited drug, to evaluate the oral efficacy of teaghrelin on PD by monitoring motor dysfunction of mice in open field, pole, and bean walking tests...
April 15, 2024: Environmental Toxicology
https://read.qxmd.com/read/38622643/optimizing-breathlessness-management-in-amyotrophic-lateral-sclerosis-insights-from-a-comprehensive-systematic-review
#37
JOURNAL ARTICLE
Catarina Bico Filipe, Nuno Reis Carreira, Paulo Reis-Pina
BACKGROUND: Breathlessness is a prevalent symptom affecting the quality of life (QOL) of Amyotrophic Lateral Sclerosis (ALS) patients. This systematic review explored the interventions for controlling breathlessness in ALS patients, emphasizing palliative care (PALC), non-invasive ventilation (NIV), opioids, and non-pharmacological strategies. METHODS: A comprehensive search of PubMed, Cochrane Library, and Web of Science databases was conducted. Eligibility criteria encompassed adults with ALS or motor neuron disease experiencing breathlessness...
April 16, 2024: BMC Palliative Care
https://read.qxmd.com/read/38621743/animal-models-of-fus-proteinopathy-a-systematic-review
#38
REVIEW
Alexander Rezvykh, Daniil Shteinberg, Evgeny Bronovitsky, Aleksey Ustyugov, Sergei Funikov
Mutations that disrupt the function of the DNA/RNA-binding protein FUS could cause amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. One of the key features in ALS pathogenesis is the formation of insoluble protein aggregates containing aberrant isoforms of the FUS protein in the cytoplasm of upper and lower motor neurons. Reproduction of human pathology in animal models is the main tool for studying FUS-associated pathology and searching for potential therapeutic agents for ALS treatment...
January 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38621565/functional-modification-of-recombinant-brain-derived-neurotrophic-factor-and-its-protective-effect-against-neurotoxicity
#39
JOURNAL ARTICLE
Chang Liu, Qi Yan, Xuying Ding, Meijun Zhao, Chen Chen, Qian Zheng, Huiying Yang, Yining Xie
Brain-derived neurotrophic factor (BDNF) is a neurotrophic protein that promotes neuronal survival, increases neurotransmitter synthesis, and has potential therapeutic effects in neurodegenerative and psychiatric diseases, but its drug development has been limited by the fact that recombinant proteins of BDNF are unstable and do not penetrate the blood-brain barrier (BBB). In this study, we fused a TAT membrane-penetrating peptide with BDNF to express a recombinant protein (TBDNF), which was then PEG-modified to P-TBDNF...
April 13, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38621442/long-timescale-atomistic-simulations-uncover-loss-of-function-mechanisms-of-uncharacterized-angiogenin-mutants-associated-with-als
#40
JOURNAL ARTICLE
Deeksha Dewangan, Aryaman Joshi, Aditya K Padhi
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive degeneration of motor neurons, resulting in respiratory failure and mortality within 3-5 years. Mutations in the Angiogenin (ANG) cause loss of ribonucleolytic and nuclear translocation activities, contributing to ALS pathogenesis. This study focused on investigating two uncharacterized ANG mutations, T11S and R122H, newly identified in the Project Mine consortium. Using extensive computational analysis, including structural modeling and microsecond-timescale molecular dynamics (MD) simulations, we observed conformational changes in the catalytic residue His114 of ANG induced by T11S and R122H mutations...
April 13, 2024: Archives of Biochemistry and Biophysics
keyword
keyword
33845
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.